---
$id: https://graph.org.ai/products/commodity/51162621
$type: Product
source: UNSPSC
code: "51162621"
title: "Dipropizine or dropropizine"
class: "51162600"
classTitle: "Antitussives and associated cough remedies"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dipropizine or dropropizine

**UNSPSC Code**: 51162621
**Class**: [Antitussives and associated cough remedies](Antitussives and associated cough remedies.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C13H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U0K8WHL37U, chemically known as 1,2-propanediol, 3-(4-phenyl-1-piperazinyl)-, (r,s)- but more generally known as dropropizine, which bears US NIH Compound Identifier 3169. European Medicines Agency schedules Dropropizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06412MIG. The term DROPROPIZINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules dropropizine in its Anatomical Therapeutic Chemical (ATC) Classification. DROPROPIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Dipropizine or dropropizine bears US NLM identifiers UMLS ID C0058425 and NCI Concept Code C73179. SMILES: OC(CN1CCN(CC1)C1CCCCC1)CO.

